Literature DB >> 21216954

Human T-lymphotropic virus type 1 p30 interacts with REGgamma and modulates ATM (ataxia telangiectasia mutated) to promote cell survival.

Rajaneesh Anupam1, Antara Datta, Matthew Kesic, Kari Green-Church, Nikolozi Shkriabai, Mamuka Kvaratskhelia, Michael D Lairmore.   

Abstract

Human T-lymphotropic virus type 1 (HTLV-1) is a causative agent of adult T cell leukemia/lymphoma and a variety of inflammatory disorders. HTLV-1 encodes a nuclear localizing protein, p30, that selectively alters viral and cellular gene expression, activates G(2)-M cell cycle checkpoints, and is essential for viral spread. Here, we used immunoprecipitation and affinity pulldown of ectopically expressed p30 coupled with mass spectrometry to identify cellular binding partners of p30. Our data indicate that p30 specifically binds to cellular ATM (ataxia telangiectasia mutated) and REGγ (a nuclear 20 S proteasome activator). Under conditions of genotoxic stress, p30 expression was associated with reduced levels of ATM and increased cell survival. Knockdown or overexpression of REGγ paralleled p30 expression, suggesting an unexpected enhancement of p30 expression in the presence of REGγ. Finally, size exclusion chromatography revealed the presence of p30 in a high molecular mass complex along with ATM and REGγ. On the basis of our findings, we propose that HTLV-1 p30 interacts with ATM and REGγ to increase viral spread by facilitating cell survival.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21216954      PMCID: PMC3045020          DOI: 10.1074/jbc.M110.176354

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Immune defects in 28-kDa proteasome activator gamma-deficient mice.

Authors:  Lance F Barton; Herbert A Runnels; Todd D Schell; Yunjung Cho; Reta Gibbons; Satvir S Tevethia; George S Deepe; John J Monaco
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

2.  Lysine 188 substitutions convert the pattern of proteasome activation by REGgamma to that of REGs alpha and beta.

Authors:  J Li; X Gao; J Ortega; T Nazif; L Joss; M Bogyo; A C Steven; M Rechsteiner
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

3.  Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300.

Authors:  W Zhang; J W Nisbet; B Albrecht; W Ding; F Kashanchi; J T Bartoe; M D Lairmore
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

4.  Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein.

Authors:  Kohji Moriishi; Tamaki Okabayashi; Kousuke Nakai; Kyoji Moriya; Kazuhiko Koike; Shigeo Murata; Tomoki Chiba; Keiji Tanaka; Ryosuke Suzuki; Tetsuro Suzuki; Tatsuo Miyamura; Yoshiharu Matsuura
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

5.  HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication.

Authors:  Christophe Nicot; Miroslav Dundr; Julie M Johnson; Jake R Fullen; Norma Alonzo; Risaku Fukumoto; Gerald L Princler; David Derse; Tom Misteli; Genoveffa Franchini
Journal:  Nat Med       Date:  2004-01-18       Impact factor: 53.440

6.  Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator.

Authors:  Ihab Younis; Lyne Khair; Miroslav Dundr; Michael D Lairmore; Genoveffa Franchini; Patrick L Green
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

7.  DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation.

Authors:  Christopher J Bakkenist; Michael B Kastan
Journal:  Nature       Date:  2003-01-30       Impact factor: 49.962

8.  Biochemical characterization of the ataxia-telangiectasia mutated (ATM) protein from human cells.

Authors:  Aaron A Goodarzi; Susan P Lees-Miller
Journal:  DNA Repair (Amst)       Date:  2004-07-02

9.  Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion.

Authors:  Lee R Silverman; Andrew J Phipps; Andrew Montgomery; Lee Ratner; Michael D Lairmore
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  16 in total

1.  Inhibiting HDACs in a preclinical model of HTLV-1-induced adult T-cell lymphoma.

Authors:  Robert Harrod
Journal:  Leuk Res       Date:  2011-08-24       Impact factor: 3.156

2.  PA28γ is a novel corepressor of HTLV-1 replication and controls viral latency.

Authors:  Nga Ling Ko; John M Taylor; Marcia Bellon; Xue Tao Bai; Sergey P Shevtsov; Miroslav Dundr; Christophe Nicot
Journal:  Blood       Date:  2012-10-26       Impact factor: 22.113

3.  HTLV-1 Rex: the courier of viral messages making use of the host vehicle.

Authors:  Kazumi Nakano; Toshiki Watanabe
Journal:  Front Microbiol       Date:  2012-09-06       Impact factor: 5.640

4.  Comparative host protein interactions with HTLV-1 p30 and HTLV-2 p28: insights into difference in pathobiology of human retroviruses.

Authors:  Rami Doueiri; Rajaneesh Anupam; Mamuka Kvaratskhelia; Kari B Green; Michael D Lairmore; Patrick L Green
Journal:  Retrovirology       Date:  2012-08-09       Impact factor: 4.602

Review 5.  Orf-I and orf-II-encoded proteins in HTLV-1 infection and persistence.

Authors:  Dustin Edwards; Claudio Fenizia; Heather Gold; Maria Fernanda de Castro-Amarante; Cody Buchmann; Cynthia A Pise-Masison; Genoveffa Franchini
Journal:  Viruses       Date:  2011-06-17       Impact factor: 5.048

Review 6.  Molecular determinants of human T-lymphotropic virus type 1 transmission and spread.

Authors:  Michael D Lairmore; Rajaneesh Anupam; Nadine Bowden; Robyn Haines; Rashade A H Haynes; Lee Ratner; Patrick L Green
Journal:  Viruses       Date:  2011-07-12       Impact factor: 5.048

Review 7.  The DNA damage response in viral-induced cellular transformation.

Authors:  P A Nikitin; M A Luftig
Journal:  Br J Cancer       Date:  2012-01-12       Impact factor: 7.640

8.  Conference highlights of the 15th International Conference on Human Retrovirology: HTLV and related retroviruses, 4-8 June 2011, Leuven, Gembloux, Belgium.

Authors:  Fabiola Martin; Charles R M Bangham; Vincenzo Ciminale; Michael D Lairmore; Edward L Murphy; William M Switzer; Renaud Mahieux
Journal:  Retrovirology       Date:  2011-10-28       Impact factor: 4.602

9.  Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesis.

Authors:  Xue Tao Bai; Christophe Nicot
Journal:  Front Microbiol       Date:  2012-12-11       Impact factor: 5.640

10.  Accumulation of splice variants and transcripts in response to PI3K inhibition in T cells.

Authors:  Alice Riedel; Boitumelo Mofolo; Elita Avota; Sibylle Schneider-Schaulies; Ayton Meintjes; Nicola Mulder; Susanne Kneitz
Journal:  PLoS One       Date:  2013-02-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.